# Pravastatin or Atorvastatin Evaluation and Infection Therapy (TIMI22)

> **NCT00382460** · PHASE4 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 4000 (—)

## Conditions studied

- Actue Coronary Syndromes

## Interventions

- **DRUG:** PRAVASTATIN SODIUM

## Key facts

- **NCT ID:** NCT00382460
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-11
- **Primary completion:** 2003-12
- **Final completion:** 2003-12
- **Target enrollment:** 4000 (—)
- **Last updated:** 2011-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00382460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00382460, "Pravastatin or Atorvastatin Evaluation and Infection Therapy (TIMI22)". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00382460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*